Healio (5/13, Ernst) reports researchers found “entorhinal hypometabolism identified on fluorodeoxyglucose PET scans served as a ‘strong and independent predictor’ of future cognitive decline in” patients with preclinical Alzheimer’s disease. The findings were published in Neurology.

Related Links:

— “Entorhinal hypometabolism on PET scan predicts cognitive decline in preclinical AD “Julia Ernst, Healio, May 13, 2021

Healio (5/13, Gramigna) reports researchers found in a randomized clinical trial that “patients with opioid dependence who received subcutaneous buprenorphine reported higher satisfaction and lower treatment burden vs. those who took sublingual buprenorphine.” The findings were published in JAMA Network Open.

Psychiatric News (5/13) reports the study’s “results highlight the importance of using patient-reported outcomes when developing medication treatment for substance use disorders.”

Related Links:

— “Patients report subcutaneous buprenorphine preferable to sublingual formulation “Madison Weller, Healio, May 13, 2021

Healio (5/13, Gramigna) reports researchers conducted a cross-sectional study and found that “borderline personality disorder diagnosis and related criteria of self-injurious behaviors and chronic emptiness significantly increased suicide attempt risk.” The findings were published in JAMA Network Open.

Related Links:

— “Self-injurious behaviors, chronic emptiness increase suicide attempt risk in BPD “Joe Gramigna, Healio, May 13, 2021

Renal & Urology News (5/12, Schieszer) reports, “Declining kidney function appears to be strongly associated with the development of dementia among patients aged 65 years or older,” investigators concluded after analyzing “the association of estimated glomerular filtration rate (eGFR) with the risk of dementia among 329,822 residents in Stockholm accessing health care between 2006 and 2011.” Study participants “were aged 65 years or older, had no history of dementia, and had not received renal replacement therapy.” The findings were published online in the journal Neurology.

Related Links:

— “Renal Function Decline Associated With Increased Dementia Risk “John Schieszer, Renal & Urology News, May 12, 2021

Cardiovascular Business (5/12, Walter) reports, “Antidepressants, nonsteroidal anti-inflammatory drugs (NSAIDs) and oral steroids are just some of the medications that could inadvertently raise a person’s blood pressure,” investigators concluded after tracking “data from more than 27,000 participants who responded to the National Health and Nutrition Examination Survey from 2009 to 2018.” The findings are slated for presentation at ACC.21, the American College of Cardiology’s 70th annual scientific session.

Related Links:

— “Antidepressants, other common medications linked to high blood pressure “Michael Walter, Cardiovascular Business, May 12, 2021